Recent progresses in deep brain stimulation of subthalamic nucleus on Parkinson′s disease and its related depression

doi:10.3969/j.issn.1674-8115.2021.06.019

Abstract

Abstract:

Depression is a common non-motor symptom of Parkinson′s disease (PD) and is a critical factor in the reduction of life quality of PD patients. The therapeutic effect of subthalamic nucleus deep brain stimulation (STN-DBS) on PD motor symptoms has been well documented. However, their effect on the related depression in PD is inconclusive. This article reviews the epidemiological characteristics and pathogenesis of PD and its related depression, the mechanism underlying the effects of STN-DBS on PD-related depression, the imaging and electrophysiological research of STN-DBS on PD and its related depression, the effects of STN-DBS on drug use, and the effects of electrode position on emotion.

Key words: Parkinson′s disease (PD), depression, subthalamic nucleus, deep brain stimulation

CLC Number:

R742.5

Xiao-xiao ZHANG, Chen-cheng ZHANG, Yi-jie LAI, Bo-min SUN. Recent progresses in deep brain stimulation of subthalamic nucleus on Parkinson′s disease and its related depression[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 815-820.

TrendMD

References 64

1	Armstrong MJ, Okun MS. Diagnosis and treatment of parkinson disease: a review[J]. JAMA, 2020, 323(6): 548-560.
2	Dobkin RD, Menza M, Allen LA, et al. Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial[J]. Am J Psychiatry, 2011, 168(10): 1066-1074.
3	Luquin MR, Kulisevsky J, Martinez-Martin P, et al. Consensus on the definition of advanced Parkinson's disease: a neurologists-based Delphi study (CEPA study)[J]. Parkinsons Dis, 2017, 2017: 4047392.
4	Kuhlman GD, Flanigan JL, Sperling SA, et al. Predictors of health-related quality of life in Parkinson's disease[J]. Park Relat Disord, 2019, 65: 86-90.
5	Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes[J]. Mov Disord, 2006, 21(): S290-S304.
6	Combs HL, Folley BS, Berry DT, et al. Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson's disease: a meta-analysis[J]. Neuropsychol Rev, 2015, 25(4): 439-454.
7	Abbes M, Lhommée E, Thobois S, et al. Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study[J]. J Neurol Neurosurg Psychiatry, 2018, 89(8): 836-843.
8	Lhommée E, Klinger H, Thobois S, et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours[J]. Brain, 2012, 135(Pt 5): 1463-1477.
9	Lilleeng B, Gjerstad M, Baardsen R, et al. The long-term development of non-motor problems after STN-DBS[J]. Acta Neurol Scand, 2015, 132(4): 251-258.
10	Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease[J]. Mov Disord, 2008, 23(2): 183-189;quiz313.
11	Chagas MH, Moriyama TS, Felício AC, et al. Depression increases in patients with Parkinson's disease according to the increasing severity of the cognitive impairment[J]. Arq Neuropsiquiatr, 2014, 72(6): 426-429.
12	Shen CC, Tsai SJ, Perng CL, et al. Risk of Parkinson disease after depression: a nationwide population-based study[J]. Neurology, 2013, 81(17): 1538-1544.
13	Mayberg HS, Solomon DH. Depression in Parkinson's disease: a biochemical and organic viewpoint[J]. Adv Neurol, 1995, 65: 49-60.
14	Ossowska K, Lorenc-Koci E. Depression in Parkinson's disease[J]. Pharmacol Rep, 2013, 65(6): 1545-1557.
15	Arabia G, Grossardt BR, Geda YE, et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease[J]. Arch Gen Psychiatry, 2007, 64(12): 1385-1392.
16	Wang JY, Fan QY, He JH, et al. SLC6A4 repeat and single-nucleotide polymorphisms are associated with depression and rest tremor in Parkinson's disease: an exploratory study[J]. Front Neurol, 2019, 10: 333.
17	Meloni M, Puligheddu M, Carta M, et al. Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding[J]. Eur J Neurol, 2020, 27(5): 779-786.
18	Braak H, Ghebremedhin E, Rüb U, et al. Stages in the development of Parkinson's disease-related pathology[J]. Cell Tissue Res, 2004, 318(1): 121-134.
19	Kostić VS, Agosta F, Petrović I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease[J]. Neurology, 2010, 75(10): 857-863.
20	Aarsland D, Påhlhagen S, Ballard CG, et al. Depression in Parkinson disease: epidemiology, mechanisms and management[J]. Nat Rev Neurol, 2011, 8(1): 35-47.
21	Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial[J]. Lancet Neurol, 2013, 12(1): 37-44.
22	Zhou HY, Wang LB, Zhang CC, et al. Acute effects of subthalamic deep brain stimulation on motor outcomes in Parkinson's disease; 13 year follow up[J]. Front Neurol, 2019, 10: 689.
23	Chopra A, Abulseoud OA, Sampson S, et al. Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up study[J]. Psychosomatics, 2014, 55(5): 478-484.
24	Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2004, 75(6): 834-839.
25	McDonald LM, Page D, Wilkinson L, et al. Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson's disease[J]. Mov Disord, 2012, 27(3): 372-378.
26	Fabbri M, Coelho M, Guedes LC, et al. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease[J]. Parkinsonism Relat Disord, 2017, 41: 113-117.
27	Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation[J]. N Engl J Med, 1999, 340(19): 1476-1480.
28	Doshi PK, Chhaya N, Bhatt MH. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease[J]. Mov Disord, 2002, 17(5): 1084-1085.
29	Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial[J]. Ann Neurol, 2009, 65(5): 586-595.
30	Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease[J]. N Engl J Med, 2010, 362(22): 2077-2091.
31	Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients[J]. Neurology, 2002, 59(9): 1427-1429.
32	Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation[J]. J Neurol Neurosurg Psychiatry, 2002, 72(6): 701-707.
33	Strutt AM, Simpson R, Jankovic J, et al. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease[J]. Eur J Neurol, 2012, 19(1): 121-127.
34	Petersson P, Halje P, Cenci MA. Significance and translational value of high-frequency cortico-basal Ganglia oscillations in Parkinson's disease[J]. J Parkinsons Dis, 2019, 9(1): 183-196.
35	Karachi C, Yelnik J, Tandé D, et al. The pallidosubthalamic projection: an anatomical substrate for nonmotor functions of the subthalamic nucleus in Primates[J]. Mov Disord, 2005, 20(2): 172-180.
36	Hilker R, Voges J, Weisenbach S, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease[J]. J Cereb Blood Flow Metab, 2004, 24(1): 7-16.
37	Temel Y, Blokland A, Steinbusch HW, et al. The functional role of the subthalamic nucleus in cognitive and limbic circuits[J]. Prog Neurobiol, 2005, 76(6): 393-413.
38	Rodriguez-Oroz MC, Gorospe A, Guridi J, et al. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease[J]. Neurology, 2000, 55(12 ): S45-S51.
39	Kim HJ, Jeon BS, Paek SH. Nonmotor symptoms and subthalamic deep brain stimulation in Parkinson's disease[J]. J Mov Disord, 2015, 8(2): 83-91.
40	Politis M, Wu K, Loane C, et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study[J]. Neurobiol Dis, 2010, 40(1): 216-221.
41	Tan SK, Hartung H, Sharp T, et al. Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus?[J]. Neuropharmacology, 2011, 61(3): 387-399.
42	Navailles S, Benazzouz A, Bioulac B, et al. High-frequency stimulation of the subthalamic nucleus and L-3, 4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and Hippocampus in a rat model of Parkinson's disease[J]. J Neurosci, 2010, 30(6): 2356-2364.
43	Stefani A, Cerroni R, Mazzone P, et al. Mechanisms of action underlying the efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: central role of disease severity[J]. Eur J Neurosci, 2019, 49(6): 805-816.
44	Kumar R, Lozano AM, Sime E, et al. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation[J]. Neurology, 1999, 53(3): 561-566.
45	Cummings JL. Frontal-subcortical circuits and human behavior[J]. Arch Neurol, 1993, 50(8): 873-880.
46	Klauser P, Fornito A, Lorenzetti V, et al. Cortico-limbic network abnormalities in individuals with current and past major depressive disorder[J]. J Affect Disord, 2015, 173: 45-52.
47	Feldmann A, Illes Z, Kosztolanyi P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study[J]. Mov Disord, 2008, 23(1): 42-46.
48	Cardoso EF, Maia FM, Fregni F, et al. Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus[J]. Neuroimage, 2009, 47(2): 467-472.
49	Jeune F, Péron J, Grandjean D, et al. Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study[J]. Eur J Nucl Med Mol Imaging, 2010, 37(8): 1512-1520.
50	Kalbe E, Voges J, Weber T, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease[J]. Neurology, 2009, 72(1): 42-49.
51	Langner-Lemercier S, Drapier S, Naudet F, et al. Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease[J]. J Neurol, 2015, 262(4): 881-889.
52	Rappel P, Grosberg S, Arkadir D, et al. Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus[J]. Mov Disord, 2020, 35(2): 337-343.
53	Kühn AA, Hariz MI, Silberstein P, et al. Activation of the subthalamic region during emotional processing in Parkinson disease[J]. Neurology, 2005, 65(5): 707-713.
54	Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation[J]. Brain, 2010, 133(Pt 4): 1111-1127.
55	Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease[J]. Brain, 2008, 131(Pt 10): 2720-2728.
56	Alexoudi A, Shalash A, Knudsen K, et al. The medical treatment of patients with Parkinson's disease receiving subthalamic neurostimulation[J]. Parkinsonism Relat Disord, 2015, 21(6): 555-560.
57	Zibetti M, Cinquepalmi A, Angrisano S, et al. Management of antiparkinsonian therapy during chronic subthalamic stimulation in Parkinson's disease[J]. Parkinsonism Relat Disord, 2009, 15(): S76-S80.
58	Yu XX, Fernandez HH. Dopamine agonist withdrawal syndrome: a comprehensive review[J]. J Neurol Sci, 2017, 374: 53-55.
59	Brunenberg EJ, Moeskops P, Backes WH, et al. Structural and resting state functional connectivity of the subthalamic nucleus: identification of motor STN parts and the hyperdirect pathway[J]. PLoS One, 2012, 7(6): e39061.
60	Dafsari HS, Petry-Schmelzer JN, Ray-Chaudhuri K, et al. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts[J]. Brain Stimul, 2018, 11(4): 904-912.
61	Krack P, Hariz MI, Baunez C, et al. Deep brain stimulation: from neurology to psychiatry?[J]. Trends Neurosci, 2010, 33(10): 474-484.
62	Blomstedt P, Hariz MI, Lees A, et al. Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report[J]. Parkinsonism Relat Disord, 2008, 14(3): 253-256.
63	Starkstein SE, Brockman S. Management of depression in Parkinson's disease: a systematic review[J]. Mov Disord Clin Pract, 2017, 4(4): 470-477.
64	苗海锋, 马荣, 吴志强, 等. 帕罗西汀治疗帕金森病伴发抑郁障碍临床疗效与安全性分析[J]. 中国实用神经疾病杂志, 2014, 17(4): 9-12.

[1]	TANG Ye-zhou, SHI Yi-fan, HUANG Yu-xin, ZHAO Ya-juan, FU Hao, HUANG Jia, WANG Yong. Analysis on sleep quality and characteristics of depression patients with different degrees of anxiety [J]. , 2020, 40(3): 333-.
[2]	WEN Wan-jun1, CHEN Ye1, QIN Zong-hou1, LÜ Wang-qiang2, TANG Wei3, LU Wei-hong4, FAN Wei-xing2, ZHANG Chen4. Relationship between serum interleukin-6 level and depressive symptoms in schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1618-1620.
[3]	ZHAO Jun-xiong, HUA Shen, FAN Wei-xing, WANG Wei-ping, TANG Wei, ZHANG Chen. Association of SIRT1 gene with major depression and its clinical features [J]. , 2020, 40(1): 18-.
[4]	WANG Tao, ZHANG Chen-cheng, LI Dian-you, SUN Bo-min, FU Meng. Imaging law of postoperative electrode locations in deep brain stimulation for Parkinsons disease [J]. , 2020, 40(1): 64-.
[5]	PENG Yi-hua1, HUANG Ye2, NIE Lei-yan1, LIU Qiang1#, CHEN Jue1#. Reliability and validity of self-rated Family Burden Scale in families of the patients with anorexia nervosa [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(06): 804-808.
[6]	QIAN Shi-xing, FANG Yuan#, SUN Lin, QIU Qi, LIN Zhi-guang, XIAO Shi-fu, LI Xia#. Effect of citalopram on miRNA-16/serotonin transporter pathway in peripheral blood of patients with depression [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(06): 814-819.
[7]	NI Xue-ping1, 2, LI Xian-hua2, XIN Xiao2, WU Sheng-jia1, 2, SONG Ting1, HE Yang2, ZHENG Xin2. Current status of self-perceived burden and related factors in the patients with non-Hodgkin's lymphoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(06): 856-862.
[8]	ZHANG Li1, FANG Fang1, ZHU Zhi-pei2, 3, SHEN Yuan4, LIU Na5, LI Chun-bo3. Effect of simplified cognitive behavioral therapy on generalized anxiety disorder [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(05): 619-625.
[9]	YE Hui-ling, LÜ Na, FAN Qing. Review of brain mechanism of abnormal semantic processing in major depression disorder [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(05): 679-682.
[10]	CHEN Bing-xu1, LIO Ka U1, HU Jia-yu1, SU Xuan1, JIANG Meng2, MAO Jia-liang2, BU Jun2. A preliminary study on the association between psychological problems and chest pain in patients undergoing coronary angiography [J]. , 2019, 39(9): 1038-.
[11]	YU Ling-fang, ZHANG Chen. Genetic research progress of depression [J]. , 2019, 39(8): 914-.
[12]	ZHU Jun-juan,ZHANG Tian-hong,ZHANG Ling,XU Li-hua,WEI Yan-yan,TANG Ying-ying,WANG Ji-jun. Effect of accelerated repetitive transcranial magnetic stimulation on suicide ideation in depressive patients [J]. , 2019, 39(5): 534-.
[13]	YAO Ya-min, FANG Yi-ru. Action of ketamine and endocannabinoid system in rapid anti-depression therapy [J]. , 2019, 39(4): 428-.
[14]	LI Jiao-yu, QIAN Li-ping, WU Jin-jin, LI Ting, YE Shuang. Comparison of the reliability and validity of depression scales for systemic lupus erythematosus and analysis of depression-related risk factors [J]. , 2019, 39(3): 304-.
[15]	LI Jia-hui1, HE Ya-ping1, XU Gang1, YU Jin-ming2, SHI Rong3, ZHU Jing-fen1,2. Influence of depression on current smoking and smoking intention among adolescents in Shanghai [J]. , 2019, 39(2): 182-.